RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERTEATON MYASTHENIC SYNDROME (LEMS)
Publication
, Conference
Sanders, DB; Juel, VC; Harati, Y; Smith, AG; Peltier, A; Marburger, T; Lou, J-S; Pascuzzi, RM; Richman, DP; Xie, T; Jacobus, LR; Ales, KL; Jacobus, DP
Published in: MUSCLE & NERVE
October 1, 2015
Duke Scholars
Published In
MUSCLE & NERVE
EISSN
1097-4598
ISSN
0148-639X
Publication Date
October 1, 2015
Volume
52
Start / End Page
S141 / S141
Location
Honolulu, HI
Publisher
WILEY-BLACKWELL
Conference Name
American-Association-of-Neuromuscular-and-Electrodiagnostic-Medicine 62nd Annual Meeting
Related Subject Headings
- Neurology & Neurosurgery
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sanders, D. B., Juel, V. C., Harati, Y., Smith, A. G., Peltier, A., Marburger, T., … Jacobus, D. P. (2015). RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERTEATON MYASTHENIC SYNDROME (LEMS). In MUSCLE & NERVE (Vol. 52, pp. S141–S141). Honolulu, HI: WILEY-BLACKWELL.
Sanders, D. B., V. C. Juel, Y. Harati, A. G. Smith, A. Peltier, T. Marburger, J. -. S. Lou, et al. “RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERTEATON MYASTHENIC SYNDROME (LEMS).” In MUSCLE & NERVE, 52:S141–S141. WILEY-BLACKWELL, 2015.
Sanders DB, Juel VC, Harati Y, Smith AG, Peltier A, Marburger T, et al. RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERTEATON MYASTHENIC SYNDROME (LEMS). In: MUSCLE & NERVE. WILEY-BLACKWELL; 2015. p. S141–S141.
Sanders, D. B., et al. “RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERTEATON MYASTHENIC SYNDROME (LEMS).” MUSCLE & NERVE, vol. 52, WILEY-BLACKWELL, 2015, pp. S141–S141.
Sanders DB, Juel VC, Harati Y, Smith AG, Peltier A, Marburger T, Lou J-S, Pascuzzi RM, Richman DP, Xie T, Jacobus LR, Ales KL, Jacobus DP. RESULTS FROM THE DAPPER STUDY: INPATIENT DOUBLE-BLIND PLACEBO-CONTROLLED WITHDRAWAL STUDY OF 3,4-DIAMINOPYRIDINE BASE (3,4-DAP) IN SUBJECTS WITH LAMBERTEATON MYASTHENIC SYNDROME (LEMS). MUSCLE & NERVE. WILEY-BLACKWELL; 2015. p. S141–S141.
Published In
MUSCLE & NERVE
EISSN
1097-4598
ISSN
0148-639X
Publication Date
October 1, 2015
Volume
52
Start / End Page
S141 / S141
Location
Honolulu, HI
Publisher
WILEY-BLACKWELL
Conference Name
American-Association-of-Neuromuscular-and-Electrodiagnostic-Medicine 62nd Annual Meeting
Related Subject Headings
- Neurology & Neurosurgery
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences